SWTX
SpringWorks Therapeutics, Inc.
46.99
undefined x undefined
undefined x undefined
bid
ask
+
46.99
0.00%
07:00 PM
| Ytd | ||
| 1y |
day range
52 week range
| Open | Prev Close | Low | High | Mkt Cap | N/A | ||||
| Vol | 0.00 | Avg Vol | 0.00 | EPS | N/A | P/E | N/A | Forward P/E | -21.96 |
| Beta | 0.70 | Short Ratio | 1.46 | Inst. Own | 87.40% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | N/A | 200-d Avg | N/A | 1yr Est | 47.00 |
| Income Statement | |||
| Total Revenue | 49.09M | ||
| Revenues (USD) | 49.09M | ||
| Cost of Revenue | 3.53M | ||
| Gross Profit | 45.56M | ||
| Operating Expenses | 126.10M | ||
| Research and Development Expense | 49.60M | ||
| Selling, General and Administrative Expense | 76.50M | ||
| Operating Income | -80.54M | ||
| Interest Expense | 998.00K | ||
| Net Income | -83.19M | ||
| Net Income Common Stock | -83.19M | ||
| Net Income Common Stock (USD) | -83.19M | ||
| Consolidated Income | -83.19M | ||
| Earnings per Basic Share | -1.11 | ||
| Earnings per Basic Share (USD) | -1.11 | ||
| Earnings per Diluted Share | -1.11 | ||
| Earning Before Interest & Taxes (EBIT) | -82.19M | ||
| Earning Before Interest & Taxes (USD) | -82.19M | ||
| Weighted Average Shares | 74.89M | ||
| Weighted Average Shares Diluted | 74.89M | ||
| Balance Sheet | |||
| Cash and Equivalents | 64.40M | ||
| Cash and Equivalents (USD) | 64.40M | ||
| Investments | 318.88M | ||
| Investments Current | 224.10M | ||
| Investments Non-Current | 94.78M | ||
| Trade and Non-Trade Receivables | 40.35M | ||
| Current Assets | 356.32M | ||
| Property, Plant & Equipment Net | 25.83M | ||
| Total Assets | 505.36M | ||
| Debt Current | 1.70M | ||
| Total Debt | 7.39M | ||
| Current Liabilities | 82.27M | ||
| Debt Non-Current | 5.69M | ||
| Total Liabilities | 87.96M | ||
| Accumulated Retained Earnings (Deficit) | -1.24B | ||
| Accumulated Other Comprehensive Income | 442.00K | ||
| Shareholders Equity | 417.40M | ||
| Shareholders Equity (USD) | 417.40M | ||
| Assets Non-Current | 149.04M | ||
| Total Debt (USD) | 7.39M | ||
| Inventory | 12.42M | ||
| Liabilities Non-Current | 5.69M | ||
| Trade and Non-Trade Payables | 14.93M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.63M | ||
| Net Cash Flow from Financing | -10.61M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -5.97M | ||
| Capital Expenditure | -30.00K | ||
| Issuance (Purchase) of Equity Shares | -10.61M | ||
| Net Cash Flow from Investing | 73.39M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 73.42M | ||
| Net Cash Flow from Operations | -68.76M | ||
| Share Based Compensation | 29.95M | ||